A
688613
vs
S
Shanghai Composite
Over the past 12 months, Allgens Medical Technology Co Ltd has outperformed Shanghai Composite, delivering a return of +36% compared to the Shanghai Composite's +23% growth.
Stocks Performance
688613 vs Shanghai Composite
Performance Gap
688613 vs Shanghai Composite
Performance By Year
688613 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Allgens Medical Technology Co Ltd
Glance View
Allgens Medical Technology Co., Ltd. engages in the research, development, production, and sale of biomedical materials and related medical device products. The company is headquartered in Beijing, Beijing and currently employs 151 full-time employees. The company went IPO on 2021-05-21. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The firm distributes its products both in the domestic market and to overseas markets.
